Back to Trades
Total Value
$1.2M
Net $1.2M sold
Filing Date
Jun 18, 2026
4 transactions
Sales
$1.2M
4 transactions
Trade Summary
On Jun 16, 2026 through Jun 18, 2026, mccormack riley, Insider, sold $1.2M of Digimarc Corp (DMRC) across 4 transactions. The filing covers Common Stock and reflects net selling of $1.2M. Reported prices ranged from $9.46 to $10.96. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Digimarc Corp
- Ticker Symbol
- DMRC
- CIK
- 0002119322
Insider Information
- Name
- mccormack riley
- Role
- Insider
- Location
- BEAVERTON, OR
Filing Details
- Filing Date
- Jun 18, 2026
- Transaction Date
- Jun 16, 2026
- Accession Number
- 0000905148-26-002995
- Form Type
- 4
- Net Trading Amount
- -$1.2M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Common Stock | 2,275,737 | — | Other | — |
| Jun 16, 2026 | Common Stock | 69,363 | $10.83 | Sale | $751.5K |
| Jun 16, 2026 | Common Stock | 3,512 | $10.96 | Sale | $38.5K |
| Jun 17, 2026 | Common Stock | 15,003 | $10.05 | Sale | $150.7K |
| Jun 18, 2026 | Common Stock | 27,071 | $9.46 | Sale | $256.2K |
Want live alerts when mccormack riley trades again?
Download Insider Trades to track DMRC, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)On June 16, 2026, TCM Strategic Partners L.P. (the "TCM Fund") made an in-kind distribution of an aggregate 2,275,737 shares to its limited partners and its general partner, proportionately based on their respective limited partnership interests, for no consideration. Also on June 16, 2026, the TCM Fund transferred an additional 79,356 shares to TCM Strategic L.P. (the "TCM IM"), the investment manager of the TCM Fund, in a transaction exempt from Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16a-13 thereunder.
- (F2)The securities are directly owned by the TCM Fund. TCM Strategic GP LLC (the "TCM GP") is the general partner of the TCM Fund. Riley McCormack is the sole manager of the TCM GP. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of its or his indirect pecuniary interest therein, and this report shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act or for any other purpose.
- (F3)This transaction was executed in multiple trades at prices ranging from $10.50 to $11.355, inclusive. The price reported reflects the weighted average sale price. The Reporting Persons hereby undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- (F4)The securities are directly owned by the TCM IM. Riley McCormack is the founder and sole owner of the TCM IM. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of its or his indirect pecuniary interest therein, and this report shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act or for any other purpose.
- (F5)Includes 3,512 shares that were acquired by TCM GP pursuant to the pro-rata in-kind distribution by the TCM Fund on June 16, 2026, described in footnote 1 herein, which transaction was exempt from Section 16 of the Exchange Act pursuant to Rule 16a-9 thereunder.
- (F6)This transaction was executed in multiple trades at prices ranging from $10.72 to $11.345, inclusive. The price reported reflects the weighted average sale price. The Reporting Persons hereby undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- (F7)The securities are directly owned by the TCM GP. Riley McCormack is the sole manager of the TCM GP. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of its or his indirect pecuniary interest therein, and this report shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act or for any other purpose.
- (F8)This transaction was executed in multiple trades at prices ranging from $9.85 to $10.79, inclusive. The price reported reflects the weighted average sale price. The Reporting Persons hereby undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- (F9)This transaction was executed in multiple trades at prices ranging from $9.30 to $9.755, inclusive. The price reported reflects the weighted average sale price. The Reporting Persons hereby undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.